Hematopoietic stem cell transplantation and cord blood banking (13)
All Items
-
Toward clinical use of allogeneic red cell concentrates from umbilical cord blood: feasibility and process optimization: Feasibility of cord blood red cell concentrate production
-
Donor-specific anti-HLA antibodies (DSAs) in patients undergoing allogeneic hematopoietic stem cell transplantation from mismatched donors on behalf of GITMO and AIBT: Anti-HLA and DSA management in Italian Transplant Programs
-
Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02: HSCT for Aplastic Anemia with HLA-B*40:02
-
Efficiency assessment of cord blood banking and compatibility with delayed cord clamping: Delayed cord clamping is compatible with cord blood banking
-
Analysis of HLA matching between deceased organ donors and cord blood units from a national bank network as a basis for potential platforms for chimerism-based immune tolerance after solid organ transplantation: HLA match between deceased organ donors and cord blood units
-
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients: CD38 antibody impacts on HSC mobilization and clonogenicity
-
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed: Anti-HLA antibodies and DSAs in stem cell transplantation
-
Toward a definition of immunological risk for patients with anti-HLA antibodies before stem cell transplantation: Anti-HLA antibodies and stem cell transplantation
-
Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens! Solid tumor transmission from donor to recipient
-
Multi-component cord blood banking: a proof-of-concept international exercise: Multi-component cord blood banking
-
Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert Panel: CAR T leukapheresis in adult and pediatric patients
-
A survey on preoperative autologous blood donation policy in bone marrow stem cell donors in Italy: Preoperative autologous blood donation in the age of PBM
-
Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines: Timing of peripheral blood progenitor cell collection
13 Items
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more